TABLE 3.
Gene ratio | Asymptomatic smears
|
Cervical cancer whole group analysis
|
Cervical cancer cluster analysisa
|
|||||
---|---|---|---|---|---|---|---|---|
Mean ± SD | Range | Mean ± SD | Range | Mean ± SD (low, high) | n (low, high) | F | P | |
L1/E6 | 1.27 ± 0.28 | 1.03-1.67 | 0.47 ± 0.48 | 0.00-2.00 | 0.22 ± 0.23, 1.03 ± 0.39 | 45, 21 | 110.22 | <0.001 |
E1/E6 | 1.11 ± 0.26 | 0.91-1.49 | 0.90 ± 0.62 | 0.00-2.8 | 0.58 ± 0.36, 1.59 ± 0.47 | 45, 21 | 90.71 | <0.001 |
E2/E6 | 0.8 ± 0.27 | 0.55-1.18 | 0.73 ± 0.62 | 0.00-2.6 | 0.40 ± 0.32, 1.49 ± 0.49 | 46, 20 | 113.75 | <0.001 |
E1/E2 | 1.5 ± 0.21 | 1.29-1.8 | 0.81 ± 0.90 | 0.00-5.66 | 0.52 ± 0.36, 1.79 ± 1.40 | 51, 15 | 103.33 | <0.001 |
E2/(E1*E6) | 0.001 ± 0.0005 | 0.0006-0.002 | 0.0025 ± 0.003 | 0.00-0.014 | 0.0005 ± 0.0005, 0.0036 ± 0.001, 0.01 ± 0.002b | 41, 18, 7b | 307.18 | <0.001 |
n, number of cases assigned to a cluster; F, value of Fisher-Snedocor test; P, significance level of difference between the clusters.
Values correspond here to: low, medium, high.